Skip to main content

Core Scientific Inctx

For the period ended Sep 30, 2024. Filed Nov 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 6, 2024

CORZ$13.13+3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited)

For the Three Months Ended September 30, 2024

Common Stock · AdditionalPaid-In Capital · AccumulatedDeficit · TotalStockholders’Deficit
Shares · Amount
Balance at July 1, 2024187,892$2$1,930,542$(3,014,418)$(1,083,874)
Net loss———(455,259)(455,259)
Stock-based compensation——20,523—20,523
Restricted stock awards issued, net of tax withholding obligations224—2—2
Exercise of warrants51,6451553,985—553,986
Issuance of new common stock for New Secured Convertible Notes conversion40,060—235,227—235,227
Balance at September 30, 2024279,821$3$2,740,279$(3,469,677)$(729,395)

For the Nine Months Ended September 30, 2024

Common Stock · AdditionalPaid-In Capital · AccumulatedDeficit · TotalStockholders’Deficit
Shares · Amount
Balance at January 1, 2024386,883$36$1,823,260$(2,420,237)$(596,941)
Cumulative effect of adoption of ASU 2023-08, Accounting for and Disclosure of Crypto Assets———2424
Balance at January 1, 2024, adjusted386,883361,823,260(2,420,213)(596,917)
Net loss———(1,049,464)(1,049,464)
Stock-based compensation——27,957—27,957
Cancellation of common stock in connection with emergence(386,883)(36)36—
Issuance of new common stock in connection with emergence152,5762296,893—296,895
Issuance of new common stock under the Equity Rights Offering15,649—55,000—55,000
Issuance of new common stock for the Equity Rights Offering backstop commitment2,111—5,475—5,475
Issuance of new common stock for Bitmain obligation10,735—27,839—27,839
Conversion premium on the issuance of the New Secured Convertible Notes——33,202—33,202
Issuance of warrants——(345,856)—(345,856)
Exercise of stock options——9—9
Restricted stock awards issued, net of tax withholding obligations1,624—(3,390)—(3,390)
Restricted stock awards forfeited(40)————
Exercise of warrants51,6991554,405—554,406
Issuance of new common stock for New Secured Convertible Notes conversion44,585—261,772—261,772
Issuance of new common stock for PIK interest882—3,677—3,677
Balance at September 30, 2024279,821$3$2,740,279$(3,469,677)$(729,395)

For the Three and Nine Months Ended September 30, 2023

Common Stock · AdditionalPaid-In Capital · AccumulatedDeficit · TotalStockholders’Deficit
Shares · Amount
Balance at July 1, 2023379,091$36$1,790,921$—$(2,183,398)$(392,441)
Net loss———(41,146)(41,146)
Stock-based compensation——14,861—14,861
Restricted stock awards issued, net of shares withheld for tax withholding obligations7,154————
Restricted stock awards forfeited(377)————
Balance at September 30, 2023385,868$36$1,805,782$(2,224,544)$(418,726)
Balance at January 1, 2023375,225$36$1,764,368$(2,173,750)$(409,346)
Net loss———(50,794)(50,794)
Stock-based compensation——41,414—41,414
Restricted stock awards issued, net of shares withheld for tax withholding obligations11,020————
Restricted stock awards forfeited(377)————
Balance at September 30, 2023385,868$36$1,805,782$(2,224,544)$(418,726)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.